Literature DB >> 12719534

Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1.

Yan Shu1, Maya K Leabman, Bo Feng, Lara M Mangravite, Conrad C Huang, Doug Stryke, Michiko Kawamoto, Susan J Johns, Joseph DeYoung, Elaine Carlson, Thomas E Ferrin, Ira Herskowitz, Kathleen M Giacomini.   

Abstract

The organic cation transporter, OCT1, is a major hepatic transporter that mediates the uptake of many organic cations from the blood into the liver where the compounds may be metabolized or secreted into the bile. Because OCT1 interacts with a variety of structurally diverse organic cations, including clinically used drugs as well as toxic substances (e.g., N-methylpyridinium, MPP(+)), it is an important determinant of systemic exposure to many xenobiotics. To understand the genetic basis of extensive interindividual differences in xenobiotic disposition, we functionally characterized 15 protein-altering variants of the human liver organic cation transporter, OCT1, in Xenopus oocytes. All variants that reduced or eliminated function (OCT1-R61C, OCT1-P341L, OCT1-G220V, OCT1-G401S, and OCT1-G465R) altered evolutionarily conserved amino acid residues. In general, variants with decreased function had amino acid substitutions that resulted in more radical chemical changes (higher Grantham values) and were less evolutionarily favorable (lower blosum62 values) than variants that maintained function. A variant with increased function (OCT1-S14F) changed an amino acid residue such that the human protein matched the consensus of the OCT1 mammalian orthologs. Our results indicate that changes at evolutionarily conserved positions of OCT1 are strong predictors of decreased function and suggest that a combination of evolutionary conservation and chemical change might be a stronger predictor of function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719534      PMCID: PMC156299          DOI: 10.1073/pnas.0730858100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  A new statistical method for haplotype reconstruction from population data.

Authors:  M Stephens; N J Smith; P Donnelly
Journal:  Am J Hum Genet       Date:  2001-03-09       Impact factor: 11.025

2.  Predicting deleterious amino acid substitutions.

Authors:  P C Ng; S Henikoff
Journal:  Genome Res       Date:  2001-05       Impact factor: 9.043

3.  Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1).

Authors:  M J Dresser; A T Gray; K M Giacomini
Journal:  J Pharmacol Exp Ther       Date:  2000-03       Impact factor: 4.030

4.  Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene.

Authors:  J W Jonker; E Wagenaar; C A Mol; M Buitelaar; H Koepsell; J W Smit; A H Schinkel
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

5.  Localization of GFP-tagged concentrative nucleoside transporters in a renal polarized epithelial cell line.

Authors:  L M Mangravite; J H Lipschutz; K E Mostov; K M Giacomini
Journal:  Am J Physiol Renal Physiol       Date:  2001-05

6.  Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences.

Authors:  Reinhold Kerb; Ulrich Brinkmann; Natalia Chatskaia; Dmitry Gorbunov; Valentin Gorboulev; Esther Mornhinweg; Andrea Keil; Michel Eichelbaum; Hermann Koepsell
Journal:  Pharmacogenetics       Date:  2002-11

7.  Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome.

Authors:  S Toh; M Wada; T Uchiumi; A Inokuchi; Y Makino; Y Horie; Y Adachi; S Sakisaka; M Kuwano
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

8.  Cell membrane transport of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the liver and systemic bioavailability.

Authors:  M C Yang; A J McLean; D G Le Couteur
Journal:  Biochem Biophys Res Commun       Date:  2001-11-23       Impact factor: 3.575

9.  Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function.

Authors:  Maya K Leabman; Conrad C Huang; Michiko Kawamoto; Susan J Johns; Douglas Stryke; Thomas E Ferrin; Joseph DeYoung; Travis Taylor; Andrew G Clark; Ira Herskowitz; Kathleen M Giacomini
Journal:  Pharmacogenetics       Date:  2002-07

10.  Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin.

Authors:  De-Sheng Wang; Johan W Jonker; Yukio Kato; Hiroyuki Kusuhara; Alfred H Schinkel; Yuichi Sugiyama
Journal:  J Pharmacol Exp Ther       Date:  2002-08       Impact factor: 4.030

View more
  72 in total

1.  Natural variation in human membrane transporter genes reveals evolutionary and functional constraints.

Authors:  Maya K Leabman; Conrad C Huang; Joseph DeYoung; Elaine J Carlson; Travis R Taylor; Melanie de la Cruz; Susan J Johns; Doug Stryke; Michiko Kawamoto; Thomas J Urban; Deanna L Kroetz; Thomas E Ferrin; Andrew G Clark; Neil Risch; Ira Herskowitz; Kathleen M Giacomini
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

Review 2.  The pharmacogenetics of metformin.

Authors:  Jose C Florez
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

3.  Genetic polymorphisms of the organic cation transporter 1 gene (SLC22A1) within the Cape Admixed population of South Africa.

Authors:  Morne Du Plessis; Brendon Pearce; Clifford Jacobs; Nisreen Hoosain; Mongi Benjeddou
Journal:  Mol Biol Rep       Date:  2014-11-15       Impact factor: 2.316

4.  PharmGKB summary: very important pharmacogene information for SLC22A1.

Authors:  Srijib Goswami; Li Gong; Kathleen Giacomini; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-06       Impact factor: 2.089

Review 5.  Regulation of organic cation transport.

Authors:  Giuliano Ciarimboli; Eberhard Schlatter
Journal:  Pflugers Arch       Date:  2004-11-16       Impact factor: 3.657

6.  Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function.

Authors:  Ying Chen; Kristen Teranishi; Shuanglian Li; Sook Wah Yee; Stephanie Hesselson; Doug Stryke; Susan J Johns; Thomas E Ferrin; Pui Kwok; Kathleen M Giacomini
Journal:  Pharmacogenomics J       Date:  2009-01-27       Impact factor: 3.550

7.  Functional organic cation transporters mediate osteogenic response to metformin in human umbilical cord mesenchymal stromal cells.

Authors:  Faisal E Al Jofi; Tao Ma; Dong Guo; Monica P Schneider; Yan Shu; Hockin H K Xu; Abraham Schneider
Journal:  Cytotherapy       Date:  2018-03-16       Impact factor: 5.414

8.  Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.

Authors:  Yan Shu; Steven A Sheardown; Chaline Brown; Ryan P Owen; Shuzhong Zhang; Richard A Castro; Alexandra G Ianculescu; Lin Yue; Joan C Lo; Esteban G Burchard; Claire M Brett; Kathleen M Giacomini
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 9.  Pharmacogenetics of metformin response: a step in the path toward personalized medicine.

Authors:  Marc L Reitman; Eric E Schadt
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

10.  Expression of mRNA transcripts encoding membrane transporters detected with whole transcriptome sequencing of human brain and liver.

Authors:  Amy Webb; Audrey C Papp; Jonathan C Sanford; Kun Huang; Jeffrey D Parvin; Wolfgang Sadee
Journal:  Pharmacogenet Genomics       Date:  2013-05       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.